A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

There are two main types of lung cancer: small cell and non-small cell. According to the American Cancer Society, non-small ...

Cullinan Therapeutics has announced that its lead asset has aced a midstage lung cancer trial—but the biotech is keeping the ...

本文仅供中国大陆地区执业的医学药学专业人士参考，如您非前述专业人士，请离开本页面 本文仅供医疗卫生等专业人士参考审批码：TML0038594，有效期为 2025-01-21 至 2026-01-20，资料过期，视同作废内容策划：方程项目审核：于轩题图来源：图虫创意参考文献：[1]Fan Y, Zhou JY, Zhao Y, et al. Efficacy, safety, and ...

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...

Among patients with stage IA non-small cell lung cancer, long-term survival was better with lobectomy or segmentectomy vs. wedge resection, according to results presented at the Society of Thoracic ...

Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...

We must come together to combat air pollution and move to clean energy to prevent more needless deaths from lung cancer.

导 ...

Obesity was associated with improved overall survival (OS) after curative resection in patients with non-small cell lung cancer (NSCLC), particularly those who did not have low sk ...

Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from ...